Is Amygdalin Outcomes Weighing Detriments of Sorafenib Treatment In Female Mice With Kidney Injury Induced By Ehrlich Ascites Carcinoma Model? Preliminary study - Egyptian Knowledge Bank - troweb

194378

Is Amygdalin Outcomes Weighing Detriments of Sorafenib Treatment In Female Mice With Kidney Injury Induced By Ehrlich Ascites Carcinoma Model? Preliminary study

Article

Last updated: 24 Dec 2024

Overview Similar Items

Article

Amygdalin Enhances the Antitumor Effect of Sorafenib

Article

Effect of Sorafenib on Liver Biochemistry Prior to Vitamin B17 Coadministration in Ehrlich Ascites Carcinoma Mice Model: Preliminary Phase Study

Article

In vivo study using Amygdalin against mammalian tumors in a mice model

Article

Effect of Amygdalin (Vitamin B17) on Induced Mammary Tumor in young Virgin Female Albino Rats: Histological and Morphometric Study

Article

Evaluation of the renal protection conferred by amygdalin against animal growth regulator Boldjan induced renal toxicity and injury in male rats

Article

The efficiency of amygdalin and doxorubicin combination on hepatocellular carcinoma and stromal myofibroblastic prostatic cells

Article

The Effect of Vitamin B17 on Cardiomyopathy against Ehrlich Tumor Development in Female Mice

Article

The Anticancer Impact of Anthraquinones and Sorafenib on Rat Liver Cancer

Article

The effect of "3, 6 diamino-5-cyano-4-(p-chloro phenyl) - Pyrazolo [3, 4- b] pyridine” on Ehrlich ascites carcinoma in mice

Article

Biochemical Evaluation of Antitumor Activity of Vitamin B17 Alone or in Combination with Platinum Based Drugs Against Ehrlich Ascites Carcinoma in Female Rats